Figure 4From: Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin Network of genes identified using Ingenuity Pathway Analysis. A. Network including ECM and other genes altered in cisplatin derived resistant cells. B. Network including proteasome genes and other genes altered in doxorubicin resistant cells. C. Network containing translation genes as well as other genes differentially expressed in paclitaxel-derived drug-resistant cellsBack to article page